Literature DB >> 25337607

A severe recessive and a mild dominant form of Charcot-Marie-Tooth disease associated with a newly identified Glu222Lys GDAP1 gene mutation.

Dagmara Kabzińska1, Katarzyna Kotruchow1, Joanna Cegielska2, Irena Hausmanowa-Petrusewicz1, Andrzej Kochański1.   

Abstract

Charcot-Marie-Tooth (CMT) disease caused by mutations in the GDAP1 gene has been shown to be inherited via traits that may be either autosomal recessive (in the majority of cases) [CMT4A] or autosomal dominant [CMT2K]. CMT4A disease is characterized by an early onset, and a severe clinical course often leading to a loss of ambulation, whereas CMT2K is characterized by a mild clinical course of benign axonal neuropathy beginning even in the 6th decade of life. Clinical data from a GDAP1 mutated patient suggests that the presence of a particular mutation is associated with a certain trait of inheritance. The association of a particular GDAP1 gene mutation and a dominant or recessive trait of inheritance is of special importance for genetic counseling and the prenatal diagnostics as regards severe forms of CMT. In the present study we report on two CMT families in which a newly identified Glu222Lys mutation within the GDAP1 gene segregates both in autosomal dominant and recessive traits. Our study shows that at least some GDAP1 gene mutations may segregate with the CMT phenotype as both dominant and recessive traits. Thus, genetic counseling for CMT4A/CMT2K families requires more extensive data on GDAP1 phenotype-genotype correlations.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25337607

Source DB:  PubMed          Journal:  Acta Biochim Pol        ISSN: 0001-527X            Impact factor:   2.149


  6 in total

1.  [Analysis of GDAP1 gene mutation in a pedigree with autosomal dominant Charcot-Marie-Tooth disease].

Authors:  Li Qin; Canhong Yang; Tianming Lü; Lanying Li; Dandan Zong; Yueying Wu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-01-30

2.  Genotype-phenotype correlation and frequency of distribution in a cohort of Chinese Charcot-Marie-Tooth patients associated with GDAP1 mutations.

Authors:  Pukar Singh Pakhrin; Yongzhi Xie; Zhengmao Hu; Xiaobo Li; Lei Liu; Shunxiang Huang; Binghao Wang; Zihan Yang; Jiejun Zhang; Xin Liu; Kun Xia; Beisha Tang; Ruxu Zhang
Journal:  J Neurol       Date:  2018-01-25       Impact factor: 4.849

3.  Validation of differential GDAP1 DNA methylation in alcohol dependence and its potential function as a biomarker for disease severity and therapy outcome.

Authors:  Christof Brückmann; Adriana Di Santo; Kathrin Nora Karle; Anil Batra; Vanessa Nieratschker
Journal:  Epigenetics       Date:  2016-04-29       Impact factor: 4.528

4.  A Network Pharmacology Approach for the Identification of Common Mechanisms of Drug-Induced Peripheral Neuropathy.

Authors:  Guillermo de Anda-Jáuregui; Brett A McGregor; Kai Guo; Junguk Hur
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2019-02-20

5.  The GDAP1 p.Glu222Lys Variant-Weak Pathogenic Effect, Cumulative Effect of Weak Sequence Variants, or Synergy of Both Factors?

Authors:  Dagmara Kabzińska; Katarzyna Chabros; Joanna Kamińska; Andrzej Kochański
Journal:  Genes (Basel)       Date:  2022-08-27       Impact factor: 4.141

6.  Pathogenic Effect of GDAP1 Gene Mutations in a Yeast Model.

Authors:  Weronika Rzepnikowska; Joanna Kaminska; Dagmara Kabzińska; Andrzej Kochański
Journal:  Genes (Basel)       Date:  2020-03-14       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.